Clinical Trials Browser

OTHER × Pancreatic Neoplasms × adagrasib × Clear all

NCT05634525 2025-07-25

Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms